Interestingly, treatment of BCL6-expressing Burkitt lymphoma cells and Burkitt lymphoma xenograft mice with a dual SIRT1 and SIRT2 inhibitor, cambinol, produced a potent antitumor effect [39]. Here, SIRT2 is linked to Burkitt lymphoma.